Search - tctmd.com

Displaying 121 - 140 of 263

Sort: Relevancy | Date

News Daily News

Program to Cut Hospital Readmissions Has Not Changed Racial Disparities in Acute MI

L.A. McKeown

January 09, 2020

News Features

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

Michael O'Riordan

December 12, 2019

News Daily News

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Michael O'Riordan

December 10, 2019

News Daily News

Cannabis Abuse Linked to Periprocedural MIs After Elective Surgeries

Shelley Wood

December 03, 2019

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

News Daily News

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

Caitlin E. Cox

November 06, 2019

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

News Daily News

Repeat Target-Lesion PCI: An Option for Public Reporting?

Michael O'Riordan

October 25, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Caitlin E. Cox

October 10, 2019

News Conference News

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News Daily News

Post-MI Mechanical Complications Infrequent but Deadly

Todd Neale

September 16, 2019

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

L.A. McKeown

September 09, 2019

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31997-X/fulltext

News Conference News ESC 2019

Ten-Year SYNTAXES Results Fix Roles for CABG, PCI in Complex CAD

Shelley Wood

September 05, 2019

News Conference News ESC 2019

Evolocumab in Acute ACS Safely Reduces LDL Cholesterol: EVOPACS

Yael L. Maxwell

August 31, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

Shelley Wood

August 05, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

Advertisement

Program to Cut Hospital Readmissions Has Not Changed Racial Disparities in Acute MI

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Cannabis Abuse Linked to Periprocedural MIs After Elective Surgeries

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Repeat Target-Lesion PCI: An Option for Public Reporting?

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Post-MI Mechanical Complications Infrequent but Deadly

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

Ten-Year SYNTAXES Results Fix Roles for CABG, PCI in Complex CAD

Evolocumab in Acute ACS Safely Reduces LDL Cholesterol: EVOPACS

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content